Moneycontrol PRO
HomeAuthorMadhuchanda dey News

Madhuchanda Dey

Head Research

Moneycontrol

Mindtree: How should investors read into the possible change in control?

BUSINESS

Mindtree: How should investors read into the possible change in control?

A change in ownership with an international major of repute can help sustain the premium, although near-term movement in the stock may get impacted by the deal valuation

Is a possible stake sale to LIC the best solution to IDBI’s problems?

BUSINESS

Is a possible stake sale to LIC the best solution to IDBI’s problems?

IDBI is not a lone case, there are about a dozen more banks whose capital position is precarious and they wouldn’t be in a position to raise capital from the market. The moot question remains, how many will LIC bail out?

COMMENT-The US-China trade war has no winners, and markets will have to live with it

BUSINESS

COMMENT-The US-China trade war has no winners, and markets will have to live with it

This is a war without a cease-fire in sight. This is a fact global markets will have to digest.

RPG Life Sciences – Track for the long term

BUSINESS

RPG Life Sciences – Track for the long term

The management medium term goal of Rs 1,000 crore turnover by FY22 looks like a tall task now

Credit growth improved in FY18 – who did it benefit?

BUSINESS

Credit growth improved in FY18 – who did it benefit?

For every additional Rs 100 of deposits in the banking system, Rs 55 is attracted by the 15 private banks and Rs 45 goes to the 21 public sector banks

Why creating a 'bad bank' is a better idea than simply throwing money at PSBs

BUSINESS

Why creating a 'bad bank' is a better idea than simply throwing money at PSBs

Sweden, Finland and Ireland have all used bad banks to help end financial crises. In Asia, South Korea and China had resorted to creation of bad banks as well

COMMENT | Wary of trampling on green shoots, RBI may tiptoe to August before hiking rates

BUSINESS

COMMENT | Wary of trampling on green shoots, RBI may tiptoe to August before hiking rates

While inflationary pressure beckons attention, our fragile economic growth warrants nurturing.

VA Tech Wabag – difficult FY18 but promising long-term outlook available at a decent valuation

BUSINESS

VA Tech Wabag – difficult FY18 but promising long-term outlook available at a decent valuation

While the stock performance in the near-term is largely contingent on resolving the receivable issue and traction in large orders, we see limited downside and significant upside

Karur Vysya Bank – small but getting smarter with end of asset quality woes near

BUSINESS

Karur Vysya Bank – small but getting smarter with end of asset quality woes near

While Q1 FY19 is likely to be another soft quarter for KVB, we are building in a revival in the second half of FY19. At 1.1 times book and 1.4 times adjusted book of FY19, the consolidation phase offers a great opportunity to accumulate this stock for the long term.

Can equities remain indifferent to the rise in bond yields?

BUSINESS

Can equities remain indifferent to the rise in bond yields?

Market experts feel that it is only a matter of time before the stock market reacts to the surge in bond yields.

Why should you buy Federal Bank now?

BUSINESS

Why should you buy Federal Bank now?

This middle-of-the-road mid-sized entity under the new savvy management has by and large crossed the asset quality problem. It has recently raised capital and looks set to accelerate growth.

A rate hike could be less than a year away, so cut exposure to leveraged companies

INDIA

A rate hike could be less than a year away, so cut exposure to leveraged companies

The notorious combination of falling growth and rising prices commonly referred to as a stagflation usually hamstrings central banks.

Jenburkt Pharma: A steady performer in the smallcap space

BUSINESS

Jenburkt Pharma: A steady performer in the smallcap space

While the Q1 FY18 performance was disappointing, performance has improved sharply in the quarter gone by. We derive valuation comfort given the steady track record of profitability and superior return ratios.

Looking past the RBI's status quo: Are there signs the rate cut cycle is ending?

BUSINESS

Looking past the RBI's status quo: Are there signs the rate cut cycle is ending?

What was loud and clear was the RBI’s stance on future rates – at least in the foreseeable future, there is no possibility of a rate cut; depending on the inflation trajectory, one shouldn’t be surprised if the next move is a rate increase.

Should minority shareholders be excited about the new Infosys boss?

BUSINESS

Should minority shareholders be excited about the new Infosys boss?

While the near-term guidance is still muted and lower than the industry, the management change and payout policy should limit downside in the stock, making it a candidate to accumulate on weakness.

Mangalam Drugs & Organics – valuation comfort for this small cap

BUSINESS

Mangalam Drugs & Organics – valuation comfort for this small cap

For a company on a turnaround journey where the return ratios have started looking up meaningfully, the undemanding valuation at 9X FY19 projected earnings should be looked at seriously by investors

Good quarter from Safari – Are luggage companies still a good bet after the stellar run?

BUSINESS

Good quarter from Safari – Are luggage companies still a good bet after the stellar run?

While the sector is dominated by unorganised players, the outlook for the organised players looks promising. Despite the run up in stock prices, investors should keep an eye on this sector for steady earnings growth.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347